CHARLOTTE, N.C., May 14, 2026 (GLOBE NEWSWIRE) -- Sonablate, a global leader in High-Intensity Focused Ultrasound (HIFU) technology, today announced the launch of the SONA FUSION Registry (Sonablate ...

CHARLOTTE, NC / ACCESSWIRE / July 6, 2018 / A 5-year multicenter study following focal therapy for prostate cancer, with the Sonablate HIFU technology, has been published and shows it is possible to ...

CHARLOTTE, N.C., July 9 USHIFU, LLC, a global leader innon invasive high intensity focused ultrasound (HIFU) technology, is proud toannounce sponsorship of the Sonablate(R) International HIFU Registry ...

CHARLOTTE, N.C., April 09, 2026 (GLOBE NEWSWIRE)-- Sonablate, a global leader in focused ultrasound technologies, today announced key additions to its leadership team as it scales "precision sound ...

CHARLOTTE, N.C., May 28 /PRNewswire/ -- USHIFU, LLC (US HIFU), a world leader in minimally invasive high intensity focused ultrasound (HIFU) technologies and manufacturer of the Sonablate® 500 ...

SonaCare Medical has reported five-year outcomes from a study of focal therapy using its Sonablate high-intensity focused ultrasound (HIFU) system. The multicentre study included 625 patients with ...

The US Food and Drug Administration has approved SonaCare Medical's Sonablate 450 focused ultrasound system for the ablation of prostate tissue. Focused ultrasound enables treatment of organ-confined ...

First multinational initiative dedicated to long-term HIFU outcomes in prostate cancer and BPH aims to help close the evidence gap in incision-free prostate care CHARLOTTE, N.C., May 14, 2026 (GLOBE ...

The MarketWatch News Department was not involved in the creation of this content. CHARLOTTE, N.C., April 09, 2026 (GLOBE NEWSWIRE) -- Sonablate, a global leader in focused ultrasound technologies, ...

Appointments support rising demand for HIFU and advance the "precision sound medicine" platform across new clinical applications CHARLOTTE, N.C., April 09, 2026 (GLOBE NEWSWIRE) -- Sonablate, a global ...